Use of hepatitis C-positive donors in transplantation
- PMID: 22666799
- PMCID: PMC3351258
- DOI: 10.6061/clinics/2012(05)19
Use of hepatitis C-positive donors in transplantation
Conflict of interest statement
Edson Abdala - clinical research with Bristol. Tania Mara Varejão Strabelli - speaker of Novartis, works with Novartis, clinical research with Merck. Silvia Vidal Campos clinical research with Bristol. Other authors - No conflicts.
References
-
- Rubin RH, Schaffner A, Speich R. Introduction to the Immunocompromised Host Society Consensus Conference on Epidemiology, Prevention, Diagnosis, and Manegment of Infections in Solid-Organ Transplant Recipients. Clin Infect Dis. 2001;33(Suppl1):S1–S4. - PubMed
-
- Gross PA, Barrett TL, Dellinger EP, Krause PJ, Martone WJ, McGowan JE, Jr, et al. Purpose of quality standards for infectious diseases: Infectious Diseases Society of America. Clin Infect Dis. 1994;18(3):421. - PubMed
-
- United States Public Health Service/Infectious Diseases Society of America (USPHS/IDSA) Prevention of Opportunistic InfectionsWorking Group. Preface to the USPHS/IDSA guidelines for the prevention of opportunistic infectionsin persons infected with human immunodeficiency virus. Clin Infect Dis. 1997;25(Suppl3):S311. - PubMed
-
- Saab S, Ghobrial RM, Ibrahim AB, Kunder G, Durazo F, Han S, et al. Hepatitis C positive grafts may be used in orthotopic liver transplantation: A matched analysis. Am J Transplant. 2003;3(9):1167–72. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical